FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Cate

Research Profile

Chemicals & Drugs

Disorders

Human Influenza

Living Beings

Procedures

Concepts & Ideas

Dose-Response Relationship, Immunologic

Phenomena

Anatomy

Nasal Mucosa

Co-author Network

Publications

TOP 3
Robert L Atmar; Thomas R Cate; Nancy Arden; Kuo Guo; Heather Hill; Wendy A Keitel; Diane Nino; Shital M Patel; John M Quarles; Janet Wells; Robert B Couch
Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine.
Shital M Patel; Robert L Atmar; Hana M El Sahly; Thomas R Cate; Wendy A Keitel
A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route.
Thomas R Cate; Yolanda Rayford; Diane Niño; Patricia L Winokur; Rebecca Brady; Robert Belshe; Wilbur H Chen; Robert L Atmar; Robert B Couch
A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Cate (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Robert L Atmar; Thomas R Cate; Nancy Arden; Kuo Guo; Heather Hill; Wendy A Keitel; Diane Nino; Shital M Patel; John M Quarles; Janet Wells; Robert B Couch
Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine.
Vaccine 2011;29(45):8066-72.
2010: Shital M Patel; Robert L Atmar; Hana M El Sahly; Thomas R Cate; Wendy A Keitel
A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route.
Vaccine 2010;28(17):3025-9.
2010: Thomas R Cate; Yolanda Rayford; Diane Niño; Patricia L Winokur; Rebecca Brady; Robert Belshe; Wilbur H Chen; Robert L Atmar; Robert B Couch
A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects.
Vaccine 2010;28(9):2076-9.
2009: Robert B Couch; Robert L Atmar; Thomas R Cate; John M Quarles; Wendy A Keitel; Nancy H Arden; Janet Wells; Diane Niño; Philip Wyde
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans.
Vaccine 2009;27(39):5344-8.
2009: Hana M El Sahly; Robert L Atmar; S M Patel; J M Wells; Thomas R Cate; M Ho; K Guo; Marcela F Pasetti; Dorothy E Lewis; Marcelo B Sztein; Wendy A Keitel
Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans.
Vaccine 2009;27(36):4905-11.
2008: Wendy A Keitel; Robert L Atmar; Diane Nino; Thomas R Cate; Robert B Couch
Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants.
The Journal of infectious diseases 2008;198(7):1016-8.
2007: Robert B Couch; Patricia L Winokur; Rebecca Brady; Robert B Belshe; Wilbur H Chen; Thomas R Cate; Bryndis Sigurdardottir; Amy Hoeper; Irene L Graham; Robert Edelman; Fenhua He; Diane Nino; Jose Capellan; Fred Ruben
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.
Vaccine 2007;25(44):7656-63.
2007: Robert L Atmar; Wendy A Keitel; Thomas R Cate; Flor M Munoz; Fred Ruben; Robert B Couch
A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults.
Vaccine 2007;25(29):5367-73.
2006: Robert L Atmar; Wendy A Keitel; Shital M Patel; Jacqueline M Katz; Dewei She; Hana M El Sahly; Justine Pompey; Thomas R Cate; Robert B Couch
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(9):1135-42.
2006: Wendy A Keitel; Robert L Atmar; Thomas R Cate; Nancy J Petersen; Stephen B Greenberg; Fred Ruben; Robert B Couch
Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons.
Archives of internal medicine 2006;166(10):1121-7.
2006: John Treanor; Gilbert M Schiff; Robert B Couch; Thomas R Cate; Rebecca C Brady; C Mhorag Hay; Mark Wolff; Dewei She; Manon M J Cox
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.
The Journal of infectious diseases 2006;193(9):1223-8.
2001: Wendy A Keitel; Thomas R Cate; D Nino; L L Huggins; H R Six; J M Quarles; Robert B Couch
Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
The Journal of infectious diseases 2001;183(2):329-332.
1998: Nikolaos G Frangogiannis; Thomas R Cate
Endocarditis and Ureaplasma urealyticum osteomyelitis in a hypogammaglobulinemic patient. A case report and review of the literature.
The Journal of infection 1998;37(2):181-4.
1998: Thomas R Cate
Impact of influenza and other community-acquired viruses.
Seminars in respiratory infections 1998;13(1):17-23.
1997: A Clinton White; Robert L Atmar; J Wilson; Thomas R Cate; Charles E Stager; Stephen B Greenberg
Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(2):230-9.
1997: Robert B Couch; Wendy A Keitel; Thomas R Cate
Improvement of inactivated influenza virus vaccines.
The Journal of infectious diseases 1997;176 Suppl 1():S38-44.
1997: Wendy A Keitel; Thomas R Cate; Robert B Couch; L L Huggins; K R Hess
Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period.
Vaccine 1997;15(10):1114-22.
1996: Innocent N Mbawuike; Pedro Piedra; Thomas R Cate; Robert B Couch
Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine.
Journal of medical virology 1996;50(2):105-11.
1996: Nikolaos G Frangogiannis; I Boridy; M Mazhar; R Mathews; S Gangopadhyay; Thomas R Cate
Cyclophosphamide in the treatment of toxic epidermal necrolysis.
Southern medical journal 1996;89(10):1001-3.
1996: Wendy A Keitel; Thomas R Cate; Robert L Atmar; C S Turner; D Nino; C M Dukes; H R Six; Robert B Couch
Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly.
Clinical and diagnostic laboratory immunology 1996;3(5):507-10.
1996: A C White; Robert L Atmar; Thomas R Cate; S R Greenberg
Enforcing antimicrobial restrictions.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1996;53(7):796-7.
1995: Edwin D Kilbourne; Robert B Couch; J A Kasel; Wendy A Keitel; Thomas R Cate; J H Quarles; B Grajower; B A Pokorny; B E Johansson
Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans.
Vaccine 1995;13(18):1799-803.
1995: Robert L Atmar; Wendy A Keitel; Thomas R Cate; J M Quarles; Robert B Couch
Comparison of trivalent cold-adapted recombinant (CR) influenza virus vaccine with monovalent CR vaccines in healthy unselected adults.
The Journal of infectious diseases 1995;172(1):253-7.
1995: Nikolaos G Frangogiannis; S Gangopadhyay; Thomas R Cate
Pemphigus of the larynx and esophagus.
Annals of internal medicine 1995;122(10):803-4.
1994: Innocent N Mbawuike; S B Dillion; S G Demuth; C S Jones; Thomas R Cate; Robert B Couch
Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein.
Vaccine 1994;12(14):1340-8.
1994: Wendy A Keitel; Robert B Couch; Thomas R Cate; K R Hess; B Baxter; J M Quarles; Robert L Atmar; H R Six
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults.
Journal of clinical microbiology 1994;32(10):2468-73.
1994: W A Keitel; Robert B Couch; Thomas R Cate; H F Maassab
Variability in infectivity of cold-adapted recombinant influenza virus vaccines in humans.
The Journal of infectious diseases 1994;169(2):477.
1993: Wendy A Keitel; Robert B Couch; J M Quarles; Thomas R Cate; B Baxter; H F Maassab
Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults.
The Journal of infectious diseases 1993;167(2):305-11.
1990: Innocent N Mbawuike; H R Six; Thomas R Cate; Robert B Couch
Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.
Journal of virology 1990;64(3):1370-4.
1990: Wendy A Keitel; Robert B Couch; Thomas R Cate; H R Six; B D Baxter
Cold recombinant influenza B/Texas/1/84 vaccine virus (CRB 87): attenuation, immunogenicity, and efficacy against homotypic challenge.
The Journal of infectious diseases 1990;161(1):22-6.
1989: Thomas R Cate
Prevention of severe lower respiratory tract infections.
Seminars in respiratory infections 1989;4(4):243-4.
1988: Wendy A Keitel; Thomas R Cate; Robert B Couch
Efficacy of sequential annual vaccination with inactivated influenza virus vaccine.
American journal of epidemiology 1988;127(2):353-64.
1986: Robert B Couch; J A Kasel; W Paul Glezen; Thomas R Cate; H R Six; Larry H Taber; Arthur L Frank; Stephen B Greenberg; J M Zahradnik; Wendy A Keitel
Influenza: its control in persons and populations.
The Journal of infectious diseases 1986;153(3):431-40.
1983: Robert B Couch; Thomas R Cate
Managing influenza in older patients.
Geriatrics 1983;38(9):61-3, 67, 71-4.
1983: Thomas R Cate; Robert B Couch; D Parker; B Baxter
Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978.
Reviews of infectious diseases 1983;5(4):737-47.
1983: J M Zahradnik; J A Kasel; R R Martin; H R Six; Thomas R Cate
Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine.
Journal of medical virology 1983;11(4):277-85.
1982: Thomas R Cate; Robert B Couch
Live influenza A/Victoria/75 (H3N2) virus vaccines: reactogenicity, immunogenicity, and protection against wild-type virus challenge.
Infection and immunity 1982;38(1):141-6.
1982: H R Six; J A Kasel; Thomas R Cate
Characterization of human serum strain-specific antihemagglutinin antibody to A/Port Chalmers/73 (H3N2) influenza virus by radioimmunoprecipitation assays.
Journal of clinical microbiology 1982;15(1):87-92.
1981: P Anderson; R A Insel; David H Smith; Thomas R Cate; Robert B Couch; W P Glezen
A polysaccharide-protein complex from Haemophilus influenzae type b. III. Vaccine trial in human adults.
The Journal of infectious diseases 1981;144(6):530-8.
1981: J M Quarles; Robert B Couch; Thomas R Cate; C B Goswick
Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza.
Antiviral research 1981;1(3):149-55.
1981: Thomas R Cate; Robert B Couch
Lack of effect of influenza virus infection on induction and expression of delayed hypersensitivity.
The Journal of infectious diseases 1981;144(3):280.
1981: R R Martin; Robert B Couch; Stephen B Greenberg; Thomas R Cate; G A Warr
Effects of infection with influenza virus on the function of polymorphonuclear leukocytes.
The Journal of infectious diseases 1981;144(3):279-80.
1980: Brian Murphy; Margaret B Rennels; R G Douglas; R F Betts; Robert B Couch; Thomas R Cate; R M Chanock; A P Kendal; H F Maassab; S Suwanagool; S B Sotman; L A Cisneros; WILLIAM ANTHONY; D R Nalin; Myron M Levine
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers.
Infection and immunity 1980;29(2):348-55.
1980: Brian Murphy; L J Markoff; R M Chanock; S B Spring; H F Maassab; A P Kendal; N J Cox; Myron M Levine; R G Douglas; R F Betts; Robert B Couch; Thomas R Cate
Genetic approaches to attenuation of influenza A viruses for man.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 1980;288(1029):401-15.